factual

Personalized cancer drug could cost $10 million under current FDA

If each personalized pancreatic cancer therapy had to pass the current FDA process as an individual product, each would cost about $10 million, and the KJ Muldoon bespoke therapy cost about $8 million and is useful only to him.

factualpending

Speaker

Jeff Coller

Evidence Quote

“That cancer therapy would be a $10 million therapy if we had to go through the current FDA for pancreatic cancer because each one of those drugs would be an individualized product”

Source

357 | Jeff Coller on mRNA, Vaccines, and Bespoke Therapeutics— Sean Carroll's Mindscape
Created: 11/17/2026, 7:10:08 AM

Your notes

Loading notes...